Table 6 Comparison of pre- and post-therapy laboratory parameters
From: Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Laboratory parameters | Baseline | Post-therapy | P value |
|---|---|---|---|
Hematotoxicity | |||
Hemoglobin, g/dL | 12.9 ± 1.5 | 12.5 ± 1.5 | 0.477 |
Platelets, 100,000/mm3 | 278.3 ± 92.2 | 256 ± 85.7 | 0.547 |
Leukocytes, cells/mm3 | 7749 ± 2121 | 7435 ± 2561 | 0.223 |
Nephrotoxicity | |||
Blood urea, mg/dL | 20.7 ± 7.4 | 23.35 ± 11.4 | 0.407 |
Serum creatinine, mg/dL | 0.84 ± 0.2 | 0.82 ± 0.2 | 0.605 |
GFR, mL/min/1.73 m2 BSA | 93.8 ± 25.2 | 92.7 ± 24.8 | 0.984 |
Hepatotoxicity | |||
Serum bilirubin, mg/dL | 0.57 ± 0.13 | 0.51 ± 0.45 | 0.442 |